

Amiocred-100 Cardiac Care
Amiocred-100 is a cardiac medicine from Novalab Cardiac & Diabetic Care containing Amiodarone Hydrochloride IP 100mg. Amiodarone is an antiarrhythmic medicine used under specialist supervision to manage certain serious heart rhythm disorders. The product is available in a 10 × 10 blister pack.
For pharmaceutical distributors, healthcare professionals and businesses exploring cardiac medicine products, understanding the composition, product specifications and pharmaceutical portfolio is important. This article introduces Amiocred-100, explains the role of its active ingredient and provides relevant product information from Novalab.
Table of Contents
ToggleAmiocred-100 is a branded tablet formulation containing Amiodarone Hydrochloride IP 100mg. It belongs to the antiarrhythmic category of medicines, which are used to manage abnormal electrical rhythms of the heart.
Amiodarone works by affecting electrical activity in cardiac cells and helping control certain abnormal heart rhythms. Its use requires careful medical evaluation because it can cause significant adverse effects and interact with other medicines.
Amiocred-100 is part of the cardiac medicine portfolio of Novalab Cardiac & Diabetic Care.
The active pharmaceutical ingredient in Amiocred-100 is Amiodarone Hydrochloride IP 100mg.
| Product specification | Details |
|---|---|
| Brand name | Amiocred-100 |
| Generic name | Amiodarone Hydrochloride |
| Strength | 100mg |
| Dosage form | Tablet |
| Pharmacological category | Antiarrhythmic |
| Packing | 10 × 10 tablets |
| Packaging type | Blister |
| Company | Novalab Cardiac & Diabetic Care |
The composition and packaging details are based on the product information supplied by Novalab.
Amiodarone is an antiarrhythmic medicine that influences the electrical signals responsible for controlling the heartbeat. It affects several cardiac ion channels and electrical conduction pathways, helping manage certain abnormal heart rhythms.
Specialists may prescribe amiodarone for selected serious arrhythmias when its benefits are considered greater than its risks. The exact indication depends on the patient’s condition, clinical assessment and applicable prescribing information.
It is not a general-purpose medicine for every irregular heartbeat and should never be started without medical advice.
Amiodarone is used in the specialist management of certain serious cardiac rhythm disorders.
Its recognised clinical uses include selected cases of ventricular arrhythmias, depending on the approved product labelling and the treating specialist’s judgement.
Some important considerations include:
The 100mg strength is not automatically the appropriate dose for every patient. The prescribed strength, frequency and duration must be decided by a qualified healthcare professional.
Amiodarone requires careful monitoring because it can affect multiple organs and may interact with other medicines.
Important precautions include:
1. Thyroid monitoring: Amiodarone can cause changes in thyroid function. Appropriate thyroid testing may be required.
2. Liver function: Liver-related adverse effects are possible, so the treating specialist may recommend regular liver function tests.
3. Lung health: Amiodarone can cause serious pulmonary toxicity. New or persistent coughing and breathlessness require prompt medical assessment.
4. Heart rhythm monitoring: ECG and heart-rate monitoring may be necessary during treatment.
5. Eye and skin effects: Vision changes and sensitivity to sunlight are possible.
6. Drug interactions: Amiodarone interacts with several medicines. Patients should inform their doctor about all prescription medicines, supplements and other treatments they use.
Patients should not discontinue or change their prescribed amiodarone dose without consulting their treating specialist.
For detailed prescribing safety information, refer to the official Amiodarone Hydrochloride drug label on DailyMed.
Cardiac medicines require careful attention to pharmaceutical quality, manufacturing standards, storage and product documentation.
For distributors and pharmaceutical businesses, it is important to evaluate:
Pharmaceutical companies should provide appropriate product information and documentation to support responsible distribution.
Novalab Cardiac & Diabetic Care focuses on cardiac and diabetic pharmaceutical formulations. Its portfolio includes products across different therapeutic categories, providing distributors with options to explore specialised pharmaceutical segments.
The company’s cardiac and diabetic product catalogue includes formulations such as:
Product availability and specifications should be confirmed directly with the company.
Explore the complete Novalab Cardiac & Diabetic Product List to learn more about its formulations.
Healthcare businesses and pharmaceutical distributors interested in Amiocred-100 can contact Novalab Cardiac & Diabetic Care for product-related information.
You can enquire about the product composition, packing, availability, applicable commercial terms and other relevant details.
Product: Amiocred-100 Tablets
Composition: Amiodarone Hydrochloride IP 100mg
Packing: 10 × 10 Blister
Company: Novalab Cardiac & Diabetic Care
Website: https://www.novalabcardiac.com/
For product enquiries, visit the Amiocred-100 product page.
Amiocred-100 contains Amiodarone Hydrochloride IP 100mg. It is an antiarrhythmic tablet formulation listed in the Novalab cardiac medicine portfolio.
Amiodarone is prescribed by specialists for selected serious abnormal heart rhythm disorders. Its use depends on the patient’s clinical condition and medical assessment.
According to Novalab’s product information, Amiocred-100 is available in a 10 × 10 blister pack.
Yes. Amiodarone requires specialist supervision because it can cause serious adverse effects and interact with other medicines. Regular monitoring may be necessary.
Amiocred-100 is listed in the product portfolio of Novalab Cardiac & Diabetic Care. Interested pharmaceutical businesses can contact the company for product and availability enquiries.
Patients should follow their specialist’s instructions and attend recommended monitoring. Thyroid, liver, lung, eye and cardiac-related adverse effects may require medical attention.
Amiocred-100 is a specialised cardiac formulation containing Amiodarone Hydrochloride IP 100mg. Its active ingredient belongs to the antiarrhythmic category and is used under specialist supervision for selected serious heart rhythm disorders.
Novalab Cardiac & Diabetic Care includes Amiocred-100 in its cardiac medicine portfolio, with a 10 × 10 blister packaging configuration.
This will close in 0 seconds